The store will not work correctly when cookies are disabled.
US9062043, Table 10, Compound 4
ID: ALA3696943
PubChem CID: 57664074
Max Phase: Preclinical
Molecular Formula: C14H9N5O
Molecular Weight: 263.26
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=c1[nH]c2cc(-c3nnn[nH]3)ccc2c2ccccc12
Standard InChI: InChI=1S/C14H9N5O/c20-14-11-4-2-1-3-9(11)10-6-5-8(7-12(10)15-14)13-16-18-19-17-13/h1-7H,(H,15,20)(H,16,17,18,19)
Standard InChI Key: AKNIDSUYOQTONF-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 23 0 0 0 0 0 0 0 0999 V2000
2.3383 -1.3500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2991 3.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 -3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -3.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2991 5.2507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0869 6.1125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.5527 7.5384 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.0527 7.5360 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5140 6.1087 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 2 1 0
15 10 1 0
6 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 16 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 263.26 | Molecular Weight (Monoisotopic): 263.0807 | AlogP: 1.86 | #Rotatable Bonds: 1 |
Polar Surface Area: 87.32 | Molecular Species: ACID | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.27 | CX Basic pKa: ┄ | CX LogP: 2.02 | CX LogD: 0.42 |
Aromatic Rings: 4 | Heavy Atoms: 20 | QED Weighted: 0.51 | Np Likeness Score: -1.28 |
References
1. (2015) Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators, |